neurology Archives -

UCB backs epilepsy-focused digital heath startup Nile AI

https://pharmaphorum.com/news/ucb-backs-epilepsy-focused-digital-heath-startup-nile-ai/

Could Lilly’s donanemab readout in Alzheimer’s boost Biogen’s prospects?

https://pharmaphorum.com/news/could-lillys-alzheimers-drug-readout-boost-biogens-prospects/

RNAi biotech Atalanta debuts with $110m plus Biogen and Roche CNS tie-ups

https://pharmaphorum.com/news/rnai-biotech-atalanta-debuts-with-110m-plus-biogen-and-roche-cns-tie-ups/

Angelini and Arvelle create neurology player with $960m merger

https://pharmaphorum.com/news/angelini-and-arvelle-create-neurology-player-with-960m-merger/

Clene goes public with gold-based neurology nanotechnology

https://pharmaphorum.com/news/clene-goes-public-with-gold-based-neurology-nanotechnology/

AI-designed serotonin tracker could help develop neurology drugs

https://pharmaphorum.com/news/us-scientists-use-ai-to-design/

2020 in review: Pharma’s progress outside of COVID-19

https://pharmaphorum.com/views-analysis-oncology/2020-review-pharmas-progress-outside-of-covid-19/

Novartis buys neurology biotech Cadent for up to $770m

https://pharmaphorum.com/news/novartis-buys-neurology-biotech-cadent-for-up-to-770m/

9th Annual Neurodegenerative Drug Development Summit

https://pharmaphorum.com/events/9th-annual-neurodegenerative-drug-development-summit/

Search